BRIEF-Seair announces default on senior debt
* Seair Inc - defaulted on terms of its senior debt senior debt and is currently in negotiations with its creditors to develop a restructuring plan
Feb 6 Cellectis SA :
* FDA grants cellectis IND approval to proceed with the clinical development of UCART123, the first gene edited off-the-shelf car t-cell product candidate developed in the U.S.
* Intends to initiate phase 1 trials in first half of 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom:)
* Sets regular quarterly dividend of $0.2425 per share Source text for Eikon: Further company coverage:
Feb 24 Citigroup Inc on Friday said that U.S. government and regulatory agencies are investigating the bank's hiring practices.